December 2, 2019 - Call for Proposals
Interested teams should contact Coulter Program Management early to confirm eligibility and explore market potential for the project.
February 14, 2020 – Applications Due
Full applications consist of a 4-page proposal, budget spreadsheet, and NIH-style Biosketches. Applications will be triaged according to eligibility and commercial exit potential, and up to 10 projects will be invited to pitch at the Triage Pitch Meeting. Currently funded teams for the 2018-2019 cycle are eligible to apply for follow-on funding.
March 10, 2020 – Oversight Committee Operating Review Meeting
Currently funded teams for the 2019-2020 funding cycle will present an update on their project to the Coulter Oversight Committee.
March 11, 2020 – Triage Pitch Meeting
Proposal teams invited to pitch for funding will prepare a brief, 5-minute PowerPoint presentation to pitch their ideas to the Coulter Oversight Committee, which consists of medical device industry professionals, technology transfer specialists, investors, and academics. A maximum of 8 teams will be selected based on the pitches to participate in an 8-week commercialization planning program, C3i Enlighten program.
March – June 2020 - C3i Enlighten Program
C3i Enlighten is a commercial due diligence and commercialization planning program that provides mentorship from industry and venture capitalist mentors; primary market research, regulatory, and competitive market landscape assessments; and reimbursement and intellectual property assessments as needed.
For more information on C3i, download the attached overview flyer.
June 10 or 11 – Project Selection Meeting
Teams present a 15-minute pitch presentation to the Oversight Committee for a funding decision.
June 2020 – Project Preparation
Teams selected for funding work with Coulter Program Management to finalize project milestones and budgets.
July 1, 2020 – Funding Begins
Funding runs for 1 year from July 1, 2020 – June 30, 2021. Teams regularly meet with Coulter Program Management to form a product development team and execute on milestones. Teams are expected to present updates to the Oversight Committee twice per funding cycle in October and February.
October 2020 – Oversight Committee Operating Review Meeting
Currently funded teams for the 2020-2021 funding cycle will present an update on their project to the Coulter Oversight Committee.